Low molecular weight natural mediators, 2'-5'-linked oligoadenylates, play an important role in interferon-
Introduction. Triphosphorylated 2'-5'-linked oligoadenylates, which can be defined by the general formula ppp(2'-5')A n , are being synthesized in the cell through interferon-induced enzyme -2'-5'-oligoadenylate synthase (OAS). These compounds play a key role in the antiviral innate immunity mechanism, participate in the cell differentiation and apoptosis processes, at the same time being involved in diabetes and atherosclerosis pathogenesis. It was demonstrated, that they can be used as effective therapeutic compounds for oncology and hematology treatment [1, 2] . Their biological activity is mainly related to the ribonuclease L (RNase L) activation: only phosphorylated 2'-5'-linked oligoadenylates are capable of activating the enzyme due to the presence of phosphate groups though. dephosphorylated, or so-called «core» 2'-5'-linked oligoadenylates, do not bind to RNase L thus leaving the enzyme inactive [1] [2] [3] .
The long-term research of 2'-5'-linked oligoadenylates is based on the «interferon hypothesis» of biological activity [1] [2] [3] [4] . It assumes that the antiviral activity of these compounds is based on the formation of phosphorylated 2'-5'-linked oligoadenylates and further activation of RNase L, which specifically cleaves viral mRNAs, therefore rendering their antiviral properties. Nevertheless, phosphorylated oligoadenylates possess a low stability within the cell: they are cleaved by phosphorylases, thus forming «core» oligoadenylates, which display a set of other activities that have nothing to do with the interferon-RNase L system. In particular, 2'-5'-linked triadenylates (2'-5'A 3 ) and their analogues possess cardio protector potential and may act as graft versus host disease (GVHD) inhibitors [5] . It is worth mentioning, that these compounds are also capable of executing the inhibiting effect on smooth muscle contraction [6] .
The biological action of «core» 2'-5'A 3 is not fully understood yet. Up to now, all target proteins are unknown. Our previous experiments identified a set of protein targets, with which the «core» 2'-5'A 3 and its analogues interact: strong binding to albumin and interferon and weak binding to immunoglobulin were demonstrated [7] . In order to investigate the ability of «core» 2'-5'A 3 to interact with a-interferon -the key protein of 2'-5'OAS/RNAase L system, responsible for antiviral cell defense -MALDI-TOF mass spectrometry was applied. It was shown, that naturally occurring 2'-5'A 3 and its epoxy-modified analogue (2'-5'A 3 -epo) bind to a-interferon, so 3'-5'-linked triadenylate does. Simultaneous binding of up to five ligand molecules was demonstrated [8] .
It is a matter of common knowledge that Ca 2+ signal transduction is an essential mechanism, ensuring various cell processes regulation. Multifunctional Ca 2+ -transducing protein Calmodulin (CaM) is one of the key proteins involved in it. As it has recently been shown in our group, native 2'-5'A 3 binding to human CaM caused an alteration of its functional profile [9] . The experimental data revealed considerable (2-3 times) increase of its Ca 2+ affinity upon interaction with «core« 2'-5'A 3 , its epoxy and 3'-cordycepin modified analogues.
Using these data as a background, we decided to perform a study, focused on another Ca 2+ -binding protein, human S100A1. It is the protein with known activity during neurological disorders and several types of cancer; its expression level serves as one of the key indicators for heart failure [10, 11] . As shown recently, the S100A1 interacts with ryanodine receptor (RyR) in heart (RyR1) and skeletal (RyR2) muscles [12] . The S100A1 shares with CaM exactly the same binding site to interact with RyR receptors [13] . The S100A1, an important regulator of calcium cycling, revealed the modulated activity of RyR in calcium-dependent way. The model activation of calcium release by RyR receptor in both hearts and skeletal muscles included knock-out RyR inhibitor (CaM).
Earlier, we have shown that dephosphorylated 2'-5'A 3 and its chemically modified analogues possess similar activity towards stimulating the Ca 2+ -currents inactivation kine tics in HVA cell cultures [14] . Other experimental results, obtained by us, demonstrate that 2'-5'A 3 stimulates the RyR mediated Ca 2+ release from the sarcoplasmatic reticulum in the smooth muscle cells [6] .
Current report demonstrates the recently obtained experimental data, proving the possibility of interaction between the «core» 2'-5'A 3 and human S100A1 protein in apo-(Ca 2+ free) form. Materials and methods. Synthesis of 2'-5'-linked oligoadenylates. Natural 2'-5'A 3 and its epoxy modified analogue (2'-5'A 3 -epoxy) were synthesized from a solution modified by phosphotriether method [15] (Fig. 1) .
Synthesis and purification of the recombinant human apo-S100A1. The synthetic gene encoding human S100A1 was cloned into pET-30a + plasmid and ex- pressed in Escherichia coli utilizing the T7 expression system. Bacterial cells were grown at 37°C in LB medium. Expression was induced by addition of 0.4 mM IPTG at OD 600 = 0.8. Bacterial culture was grown for 2 h afterward. Human S100A1 was isolated using the classical method of ammonium sulfate precipitation [16, 17] followed by the purification procedure using reversed-phase HPLC on a semi preparative Vydac C18 column [18] . The final product was identified by the electrospray ionization mass spectrometry using a Macromass Q-Tof spectrometer. The concentration in solution was estimated from its absorbance at 280 nm. For the synthesis of the recombinant 15 N-labeled human S100A1 protein, the E. coli cells were grown in M9 media containing ( 15 NH 4 ) 2 SO 4 as the sole nitrogen source and unlabeled glucose as the sole carbon source.
CD Spectroscopy. The far-UV CD spectra were recorded over 260-200 nm range on Jasco J-815 CD spectropolarimeter at 298 K in a 2 mm light path length cuvette. For the measurements, 8 mM human Ca 2+ -free form of S100A1 protein (apo-S100A1) was dissolved in a buffer that contained 5 mM Tris-HCl and 100 mM NaCl (pH 7.5). The concentration of human S100A1 in solution was controlled spectrophotometrically by measuring its UV absorbance at 280 nm using extinction coefficient 10200 (mol where q l is the observed ellipticity (degrees) at wavelength l, m is the molar concentration of protein solution and d is the path length in centimeters. The secondary structure content of human S100A1 was extracted using CDNN deconvolution software [19] . NMR Spectroscopy and S100A1 titration with 2'-5'A 3 . All NMR data sets were acquired on Varian Unity + 500 NMR spectrometer ( 1 H resonance frequency 500,606 MHz) equipped with three channels, z-gradients unit and 1 H/ 13 C/ 15 N triple resonance probe head with inverse detection. NMR sample was prepared by dissolving 0.3 mM 15 N-labeled human apo-S100A1 protein in 90 %/ 10 % H 2 O/D 2 O, 20 mM TRIS-d11 and 150 mM NaCl buffer solution. Spectra were recorded at 293 K using sodium 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) as external indirect reference with coefficients X = = 0.251449530 and X = 0.101329118 for 13 C and 15 N resonance frequencies respectively [20] . In order to obtain the detailed information about the interaction between apo-S100A1 and 2'-5'A 3 , the concentrated stock solution containing 130 mM of 2'-5'A 3 was prepared in the same buffer. The NMR titration experiment was done as four consecutive injections (10 mL each) of stock solution to previously prepared NMR sample. Every addition was followed by acquiring 2D 1 H- 15 N HSQC spectra. All recorded data were processed with the NMR Pipe [21] and analyzed with the Sparky [22] software.
Results and discussion. CD spectroscopy. Far-UV circular dichroism (CD) in the 260-200 nm range is widely used for the protein structure analysis [23] . In case of human S100A1, the recorded CD spectrum demonstrates two strong bands at around 222 and 208 nm ( a, b), which is an essential feature for the proteins with high content of a-helical structure [24] . According to the literature sources, the 3D structure of apo-S100A1 homodimer is dominated by four long a-helices with two short antiparallel b-sheets in C-terminal parts of both Ca 2+ -binding loops [25] . The secondary structure analysis revealed that more than 50 % of the protein's secondary structure content is presented by a-helical elements. The contents of b-turns and randomly coiled elements are very low (Table) . The presented CD spectra are very similar to those previously obtained in our group or published for structurally similar S100B protein [26] .
An addition of either natural 2'-5'A 3 or its epoxymodified derivative to the protein solution did not provide any dramatic changes in initial protein CD spectra shape. Nevertheless, it is demonstrated that 2'-5'A 3 oligoadenylates caused tiny alterations in 3D structure reflected in a small decrease of molar ellipticity within both helical bands (Fig. 2, A, B) . The analysis of apo-S100A1 secondary structure demonstrated that addition of the oligoadenylate at maximum concentration, either natural or epoxy-modified, led to a decrease in the a-helical conformation by 6 % (Table) . The value of error was determined by calculating the differences in evaluation of the secondary structure content within different regions of the CD spectra by the software.The value turned out to be around 2 % at the average in all cases.
NMR spectroscopy of human apo-S100A1 protein and its titration with natural 2'-5'A 3 oligoadenylates. The high-resolution 3D structure of apo-S100A1 is presented as X-type homodimeric biomolecule. Each subunit has two helix-loop-helix Ca 2+ -binding EF-hand motifs of 93 amino acid residues. The spatial structure S100A1 in solution was solved independently by several groups under slightly different conditions (buffer, pH, ionic strength) and temperatures which could lead to small differences in Ca 2+ affinity [25, 27, 28] . In the present study, the NMR data sets were acquired on NMR sample containing 300 mM of 15 N-labeled human apo-S100A1 at pH 7.2 under the same conditions as we have used recently [28] . The sequence-specific assignments of 1 (Fig. 3,  A) . The recorded experimental data could be used to obtain information about binding constants of native 2'-5'A 3 oligoadenylates to apo-S100A1 [30] . The dissociating constants extracted from the chemical shifts curves (Fig. 3, B) fall in the moderate 10 -5 ... 10 -6 M range suggested that the interaction of 2'-5'A 3 with the human apo-S100A1 protein is biologically relevant, but the specificity is not very high.
A comparison of the obtained results with known high-resolution 3D structure of the human apo-S100A1 [27, 28] gave us an idea about structural alterations caused by 2'-5'A 3 binding (Fig. 4) . It turned out, that positions of the residues with higher csp values referred to the Ca 2+ -binding loops, which constituted the central part of the EF-hand domains. Majority of these signals came from the N-terminal part of the Ca 2+ -binding motif (His18, Lys21, As 24, Lys25, Lys30), which was characterized by strong dependence on tiny changes in experimental conditions such as temperature, pH or/ and ionic strength of solution. The amino acid residues within the C-terminal region of the protein globule demonstrated lower csp values upon the interaction with 2'-5'A 3 -nat oligoadenylates: only Val69 and Gln72 revealed notable csp values (Fig. 4) . We suggest that even tiny structural alterations in those regions of the protein globule may cause changes in its Ca 2+ -affinity. The linker region (Glu40-Val51), in addition to Cterminal helix IV, constitutes another important region of S100A1 globule, which is mostly responsible for the interaction with target proteins/peptides. For instance, amino acid residues within the linker region are responsible for the hydrophobic contacts formation in case of interaction between S100A1 protein and Ryanodine receptor [31] . Another example is the complex between S100A1 and TRTK12 peptide, derived from actin-capping CapZ protein, which is formed via the interactions with amino acids within the «hinge» region (Phe44, Leu45, Lys49) and helix IV (Ala84, Cys85, Phe88) [32] .
We have recently shown that central position in the linker region is being held by Phe44, which forms the socalled thiol-aromatic switch that controls hydrophobic interactions within this part of the protein globule (linker-helix IV) [28] . Some of the amino acid residues, located in close proximity to Phe44, demonstrated high csp values in a response to native 2'-5'A 3 binding, namely Thr39, Glu40, and Phe44 itself (Fig. 3, A) .
As it has been previously noted, specific structural changes at the position of Phe44 further propagated to the whole linker [33] . As a result, notable alterations occurred anywhere within the S100A1 globule. In particular, the conformational changes might lead to a-helix shortening by 3-4 residues (one turn) within either the linker region [28, 33] or helix IV [25, 34] . It has recently been shown in our group, that similar structural modifications caused the increase of Ca 2+ affinity and changes in cooperativity of Ca 2+ -binding process [28] . These effects might explain small fluctuations within the S100A1 a-helical content upon binding natural 2'-5'A 3 oligoadenylates and its epoxy derivative (Table) .
As has been previously noted, the linker region together with helix IV contained several residues strongly conserved throughout the whole S100 family of proteins [28] . Comparison of the S100A1 epitops involved in the interaction process with natural 2'-5'A 3 revealed that at least some of them formed contacts with the target proteins [31, 32] . This supports an idea that oligoadenylates might regulate interactions of Ca-signaling proteins within S100 family with their targets in the similar fashion. . Surface representation of 3D structure of human apo-S100A1 protein (pdb 2LLU) solved at the same experimental conditions [28] . Residues exhibited notable csp are colored as follows: located within Nterminal (His18, Lys21, Asp24, Lys25) and C-terminal (Val69, Gln72) Ca 2+ -binding loops are highlighted in yellow and orange, respectively; residues within linker region and C-terminal part of helix IV (Glu39, Leu41, Phe44, and Glu91) are colored in red; at the intersubunit interface (Ser2, Glu 3, Ala7, Val54, Tyr74, Thr82, and Asn87) are highlighted in green It worth mentioning, that our experimental data demonstrated the impact of 2'-5'A 3 on the homodimeric interface within S100A1 globule. Some residues exhibited higher csp values (Ser2, Glu3, Ala7, Tyr74, Thr82, Asn 87, and Glu91), were involved in the formation of hydrophobic intersubunit contacts between helices I/I' and IV/ IV' (Fig. 4) . Considering a low value of solvent-accessible surface area of this particular region of the protein globule, we suppose that 2'-5'A 3 does not directly bind to residues within intersubunit interface, but rather transmits the effect to homodimeric surface upon binding to Ca 2+ -binding loop or/and linker region. The similar effect has previously been reported for structurally similar S100B protein upon binding Ca 2+ ions [35] . The tiny effect of 2'-5'A 3 binding to the apo-S100A1 homodimer interface might serve as an additional natural element, involved in the regulation of Ca 2+ transduction pathway. Conclusions. In our study we have demonstrated that 2'-5'A 3 can act as a compound, capable of altering the secondary structure of the human apo-S100A1 protein.
Addition of both natural and epoxy-modified oligoadenylates triggered the decrease of its helical structure nearly to the same extent (around 6 %). We believe that the changes within its helical structure might trigger functional Ca 2+ signal transduction regulation through tuning the function of human S100A1 protein. The presented experimental data obtained by CD and NMR spectroscopy exhibits tiny conformational alterations observed within the most important regions of the human apo-S100A1 globule caused by natural 2'-5'A 3 and its epoxy-modified derivative.
Our results suggested a possible implication of oligoadenylates in the regulation of the of S100A1 protein functioning.
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